Evidence map›Paper›PMID 36098512›Full record

ArticleJournal of virology2022

Long-Term Protective Effect of Serial Infections with H5N8 Highly Pathogenic Avian Influenza Virus in Wild Ducks.

Valentina Caliendo, Lonneke Leijten, Marco W G van de Bildt, Marjolein J Poen, Adinda Kok, Theo Bestebroer, Mathilde Richard, Ron A M Fouchier, Thijs Kuiken

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Avian influenza overview September - December 2022.EFSA journal. European Food Safety Authority · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Valentina CaliendoDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-0749-3878
Lonneke LeijtenDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Marco W G van de BildtDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Marjolein J PoenDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Adinda KokDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Theo BestebroerDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Mathilde RichardDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0003-0240-9312
Ron A M FouchierDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Thijs KuikenDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NL

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
NIAID NIH HHS 75N93021C00014NIAID NIH HHS HHSN272201400008C
6 · The paper itself

Abstract

Highly pathogenic avian influenza viruses (HPAIVs) of the Goose/Guangdong (Gs/Gd) lineage are an emerging threat to wild birds. In the 2016-2017 H5N8 outbreak, unexplained variability was observed in susceptible species, with some reports of infected birds dying in high numbers and other reports of apparently subclinical infections. This experimental study was devised to test the hypothesis that previous infection with a less-virulent HPAIV (i.e., 2014 H5N8) provides long-term immunity against subsequent infection with a more-virulent HPAIV (i.e., 2016 H5N8). Therefore, two species of wild ducks-the more-susceptible tufted duck (Aythya fuligula) and the more-resistant mallard (Anas platyrhynchos)-were serially inoculated, first with 2014 H5N8 and after 9 months with 2016 H5N8. For both species, a control group of birds was first sham inoculated and after 9 months inoculated with 2016 H5N8. Subsequent infection with the more-virulent 2016 H5N8 caused no clinical signs in tufted ducks that had previously been infected with 2014 H5N8 (

Indexed as

Animals, WildInfluenza A Virus, H5N8 SubtypeInfluenza in BirdsAnimalsAntibodies, ViralDucksSerial Infection IntervalAntibodies, ViralH5N8HPAIVmallardstufted ducks

Identifiers

PMID36098512
PMCPMC9517725
OpenAlexW4295359584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.